Korean Journal of Radiology

  • 제24권11호
  • /
  • Pages.1167-1171
  • /
  • 2023
  • /
  • 1229-6929(pISSN)
  • /
  • 2005-8330(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

Post-COVID-19 Cholangiopathy: Clinical and Radiologic Findings

  • 투고 : 2023.08.29
  • 심사 : 2023.09.18
  • 발행 : 2023.11.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Hartl L, Haslinger K, Angerer M, Semmler G, Schneeweiss-Gleixner M, Jachs M, et al. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease. Hepatology 2022;76:1563-1575
  2. Bernal-Monterde V, Casas-Deza D, Letona-Gimenez L, de la Llama-Celis N, Calmarza P, Sierra-Gabarda O, et al. SARSCoV-2 infection induces a dual response in liver function tests: association with mortality during hospitalization. Biomedicines 2020;8:328
  3. Faruqui S, Shanbhogue K, Jacobson IM. Biliary tract injury in patients with COVID-19: a review of the current literature. Gastroenterol Hepatol (N Y) 2022;18:380-387
  4. Yanny B, Alkhero M, Alani M, Stenberg D, Saharan A, Saab S. Post-COVID-19 cholangiopathy: a systematic review. J Clin Exp Hepatol 2023;13:489-499
  5. Veerankutty FH, Sengupta K, Vij M, Rammohan A, Jothimani D, Murali A, et al. Post-COVID-19 cholangiopathy: current understanding and management options. World J Gastrointest Surg 2023;15:788-798
  6. Hunyady P, Streller L, Ruther DF, Groba SR, Bettinger D, Fitting D, et al. Secondary sclerosing cholangitis following coronavirus disease 2019 (COVID-19): a multicenter retrospective study. Clin Infect Dis 2023;76:e179-e187
  7. Faruqui S, Okoli FC, Olsen SK, Feldman DM, Kalia HS, Park JS, et al. Cholangiopathy after severe COVID-19: clinical features and prognostic implications. Am J Gastroenterol 2021;116:1414-1425
  8. Ghafoor S, Germann M, Jungst C, Mullhaupt B, Reiner CS, Stocker D. Imaging features of COVID-19-associated secondary sclerosing cholangitis on magnetic resonance cholangiopancreatography: a retrospective analysis. Insights Imaging 2022;13:128
  9. Roth NC, Kim A, Vitkovski T, Xia J, Ramirez G, Bernstein D, et al. Post-COVID-19 cholangiopathy: a novel entity. Am J Gastroenterol 2021;116:1077-1082
  10. Heucke N, Keitel V. COVID-19-associated cholangiopathy: what is left after the virus has gone? Hepatology 2022;76:1560-1562
  11. Edwards K, Allison M, Ghuman S. Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection. BMJ Case Rep 2020;13:e237984
  12. Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv [Preprint]. [posted February 4, 2020; cited August 14, 2023]. https://www.biorxiv.org/conte nt/10.1101/2020.02.03.931766v1
  13. Keta-Cov research group. Intravenous ketamine and progressive cholangiopathy in COVID-19 patients. J Hepatol 2021;74:1243-1244
  14. Seo N, Kim SY, Lee SS, Byun JH, Kim JH, Kim HJ, et al. Sclerosing cholangitis: clinicopathologic features, imaging spectrum, and systemic approach to differential diagnosis. Korean J Radiol 2016;17:25-38
  15. Kulkarni AV, Khelgi A, Sekaran A, Reddy R, Sharma M, Tirumalle S, et al. Post-COVID-19 cholestasis: a case series and review of literature. J Clin Exp Hepatol 2022;12:1580-1590